Once transferred to breast cancer cells, piR-17560 stabilizes FTO mRNA, increasing FTO protein levels and enabling m6A demethylation of ZEB1 mRNA, which prevents its degradation by the m6A reader YTHDF2. This evidence concerns the gene FTO and breast carcinoma.